Loading...
Loading...
Antares Pharma
ATRS today announced the issuance of U.S.
Patent number 8,562,564, entitled “Prefilled Syringe Jet Injector”. This
patent adds to a comprehensive portfolio of patents and applications
that are intended to protect Antares' auto injector technology and
product pipeline including the VIBEX® Medi-Jet™ device
and the VIBEX® Quick Shot™ (QS) technology. This
new patent is designed to protect the use of medicament containing
prefilled syringe based auto-injectors, such as those used in OTREXUP™
and QS T (in development for testosterone deficiency).
Paul K. Wotton, Ph.D., President and Chief Executive Officer, stated,
“We continue to pursue an aggressive long-term strategy to create
comprehensive intellectual property coverage for our device technology
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in